Financial Disclosure Omitted: In the Preliminary Communication entitled “Diag- nosisofIntra-amnioticInfectionbyProteomicProfilingandIdentificationofNovel Biomarkers” published in the July 28, 2004, issue of JAMA (2004;292:462-469), afinancialdisclosurewasomitted.OregonHealthandScienceUniversity(OHSU), DrsGravett,Rosenfeld,Reddy,Jacob,Roberts,andNagallaandMrTurnerallhave asignificantfinancialinterestinProteogenixInc,acompanythatmayhaveacom- mercial interest in the results of this research and technology. Among the 3 in- vestigators involved in statistical analysis of the study (Drs Gravett, Lapidus, and Hitti),thelatter2havenopotentialfinancialinterestintheresultsofthisresearch. This potential conflict of interest has been reviewed and a management plan ap- proved by the OHSU Conflict of Interest in Research Committee, and the Integ- rity Program Oversight Council has been implemented.

Carmela Rita Balistreri, Sc

Giuseppina Candore, P

Giuseppina Colonna-Romano, Sc

Domenico Lio, MD Immunosenescence Unit Department of Pathobiology and Biomedical Methodologies University of Palermo Palermo, Italy

2340 JAMA, November 17, 2004—Vol 292, No. 19 (Reprinted)